Fulgent Genetics Inc - Company Profile
Powered by
All the data and insights you need on Fulgent Genetics Inc in one report.
- Save hours of research time and resources with
our up-to-date Fulgent Genetics Inc Strategy Report
- Understand Fulgent Genetics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians. The company offers a range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. Its major offerings include genes and panels, known mutation, genomic testing, hereditary cancer, carrier screening, tumor profiling, newborn genetics and covid-19 testing. It offers genetic tests for cardiovascular and pediatric diseases, neurological disorders, cancers, and primarily serves medical institutions, hospitals in the US, Canada, and other countries. Fulgent is headquartered in Temple City, California, the US.
Fulgent Genetics Inc premium industry data and analytics
Products and Services
Products | Services |
---|---|
Genes and Panels | Sequencing Services |
Known Mutation | Lab services |
Genomic Testing | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In April, the company entered into an agreement with Mission Bio to offer single-cell multi-omics on the Tapestri Platform on its fully customizable menu of services. |
2023 | New Products/Services | In February, the company announced the availability of new Beacon787 expanded carrier screening panel. |
2022 | Acquisitions/Mergers/Takeovers | In November, the company completed the acquisition of Fulgent Pharma Holdings, Inc. |
Competitor Comparison
Key Parameters | Fulgent Genetics Inc | Laboratory Corp of America Holdings | Natera Inc | Myriad Genetics Inc | InVitae Corp |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | El Monte | Burlington | Austin | Salt Lake City | San Francisco |
State/Province | California | North Carolina | Texas | Utah | California |
No. of Employees | 1,184 | 67,000 | 3,282 | 2,700 | 1,700 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Ming Hsieh | Chief Executive Officer; President; Chairman | Executive Board | 2016 | 67 |
Paul Kim | Chief Financial Officer | Senior Management | 2016 | 55 |
James Xie | President; Chief Operating Officer | Senior Management | 2022 | 57 |
Dr. Lawrence Weiss, M.D. | Chief Medical Officer | Senior Management | 2021 | - |
Hanlin Gao, M.D., Ph.D. | Chief Scientific Officer; Lab Director | Senior Management | 2016 | 56 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward